Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells

Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-α,<i>in Vivo</i>¹

Vidya Mohamed‐Ali, S Goodrick, A Rawesh et al. · The Journal of Clinical Endocrinology & Metabolism · 1997 · 2K citations

Inflammatory Cytokines and the Risk to Develop Type 2 Diabetes

Joachim Spranger, Anja Kroke, Matthias Möhlig et al. · Diabetes · 2003 · 1.5K citations · Full text

Interleukin-6-deficient mice develop mature-onset obesity

Ville Wallenius, Kristina Wallenius, Bo Åhrén et al. · Nature Medicine · 2002 · 1.2K citations

Obesity, Metabolic Syndrome, Inflammation +8

Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV.

Timothy J. Kieffer, Christopher H.S. McIntosh, Raymond A. Pederson · Endocrinology · 1995 · 1.1K citations

Glycobiology, Peptide Science, Peptide Chemistry +21

Interleukin-6 Increases Insulin-Stimulated Glucose Disposal in Humans and Glucose Uptake and Fatty Acid Oxidation In Vitro via AMP-Activated Protein Kinase

Andrew L. Carey, Gregory R. Steinberg, S. Lance Macaulay et al. · Diabetes · 2006 · 877 citations · Full text

Immunology, Il-6 Treatment, Fatty Acid Oxidation +20